Lack of a pharmacokinetic interaction between lansoprazole or pantoprazole and theophylline
Authors:
Open Access
- 1 March 2000
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 14 (3) , 345-352
Abstract
Aim: To study the potential pharmacokinetic interaction between lansoprazole or pantoprazole and theophylline at steady state. Methods: Theophylline 200 mg extended‐release formulation was administered twice daily on days 1–11 to 30 healthy, non‐smoking males. On days 5–11, 15 subjects received concomitant lansoprazole 30 mg once daily (o.d.) and 15 subjects received concomitant pantoprazole 40 mg o.d. Results: No significant changes in the steady‐state theophylline maximum plasma concentration (Cmax), time to Cmax (Tmax), minimum plasma concentration (Cmin), area under the plasma concentration–time curve over the 12‐h dosing interval (AUC0–12), or apparent total oral clearance (CL/F) were observed within the two treatment groups when theophylline was administered alone or in combination with lansoprazole or pantoprazole. In addition, no significant differences in the changes of steady‐state theophylline pharmacokinetics from day 4 to day 11 were noted between the two treatment groups. Treatment with theophylline in combination with either lansoprazole or pantoprazole was well tolerated. All adverse events were transient and rated mild to moderate in severity. Conclusion: Co‐administration of either lansoprazole or pantoprazole in healthy subjects does not significantly affect the steady‐state pharmacokinetics of theophylline at the therapeutic doses tested.Keywords
This publication has 16 references indexed in Scilit:
- Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazoleBritish Journal of Clinical Pharmacology, 1998
- Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugsEuropean Journal of Gastroenterology & Hepatology, 1996
- Pharmacokinetic Interaction Between Lansoprazole and TheophyllineTherapeutic Drug Monitoring, 1995
- The continuing development of proton pump inhibitors with particular reference to pantoprazoleAlimentary Pharmacology & Therapeutics, 1995
- Metabolism of theophylline by cDNA‐expressed human cytochromes P‐450.British Journal of Clinical Pharmacology, 1995
- Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism.British Journal of Clinical Pharmacology, 1994
- Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolismBritish Journal of Clinical Pharmacology, 1993
- Pharmacokinetic Interactions Between Theophylline and Other Medication (Part I)1Clinical Pharmacokinetics, 1991
- The Pharmacokinetics of Omeprazole in Humans—A Study of Single Intravenous and Oral DosesTherapeutic Drug Monitoring, 1990
- A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailabilityJournal of Pharmacokinetics and Biopharmaceutics, 1987